APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bioactive Protein and Peptides

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Bioactive Protein and Peptides Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

13 August 2026192 pages

Choose your research edition.

Industry ResearchBioactive Protein and Peptides Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Bioactive Protein and Peptides Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Bioactive Protein and Peptides Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bioactive Protein and Peptides Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Bioactive Protein and Peptides Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Bioactive Protein and Peptides market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Bioactive Protein and Peptides is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Bioactive Protein and Peptides is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bioactive Protein and Peptides is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Bioactive Protein and Peptides is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Bioactive Protein and Peptides include Gelita, Kerry Group, Vital Proteins, Rousselot, BRF Ingredients, Bunge Ltd, Ingredia Nutritional, Gelatines Weishardt and PanTheryx, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Bioactive Protein and Peptides market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Bioactive Protein and Peptides and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Bioactive Protein and Peptides sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Bioactive Protein and Peptides market size, projected growth trends, production technologies, key applications, and end-use industries.

Bioactive Protein and Peptides Segment by Company

Gelita

Kerry Group

Vital Proteins

Rousselot

BRF Ingredients

Bunge Ltd

Ingredia Nutritional

Gelatines Weishardt

PanTheryx

Hubei Reborn Biotech

Seagarden

Shandong Hengxin Biotech

Baotou Dongbao Bio-Tech

Wuhan Jiushengtang Biotech

Morinaga Milk

Collagile

Nuritas

SmartPEP

Bioactive Protein and Peptides Segment by Type

Plant Source

Animal Source

Bioactive Protein and Peptides Segment by Application

Functional Food

Dietary Supplements

Personal Care

Animal Nutrition

Other

Bioactive Protein and Peptides Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bioactive Protein and Peptides market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bioactive Protein and Peptides and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bioactive Protein and Peptides.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Bioactive Protein and Peptides market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Bioactive Protein and Peptides manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Bioactive Protein and Peptides in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Bioactive Protein and Peptides in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Bioactive Protein and Peptides Industry Trends Table 2. Bioactive Protein and Peptides Industry Drivers Table 3. Bioactive Protein and Peptides Industry Opportunities and Challenges Table 4. Bioactive Protein and Peptides Industry Restraints Table 5. Global Bioactive Protein and Peptides Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Bioactive Protein and Peptides Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Bioactive Protein and Peptides Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Bioactive Protein and Peptides Sales Market Share by Manufacturers Table 9. Global Bioactive Protein and Peptides Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Bioactive Protein and Peptides Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Bioactive Protein and Peptides Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Bioactive Protein and Peptides Manufacturers, Product Type & Application Table 13. Global Bioactive Protein and Peptides Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Bioactive Protein and Peptides by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Plant Source Table 17. Major Manufacturers of Animal Source Table 18. Global Bioactive Protein and Peptides Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Bioactive Protein and Peptides Sales by Type (2021-2026) & (k units) Table 20. Global Bioactive Protein and Peptides Sales by Type (2027-2032) & (k units) Table 21. Global Bioactive Protein and Peptides Sales Market Share by Type (2021-2026) Table 22. Global Bioactive Protein and Peptides Sales Market Share by Type (2027-2032) Table 23. Global Bioactive Protein and Peptides Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Bioactive Protein and Peptides Revenue by Type (2021-2026) & (k units) Table 25. Global Bioactive Protein and Peptides Revenue by Type (2027-2032) & (k units) Table 26. Global Bioactive Protein and Peptides Revenue Market Share by Type (2021-2026) Table 27. Global Bioactive Protein and Peptides Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Functional Food Table 29. Major Manufacturers of Dietary Supplements Table 30. Major Manufacturers of Personal Care Table 31. Major Manufacturers of Animal Nutrition Table 32. Major Manufacturers of Other Table 33. Global Bioactive Protein and Peptides Sales by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Bioactive Protein and Peptides Sales by Application (2021-2026) & (k units) Table 35. Global Bioactive Protein and Peptides Sales by Application (2027-2032) & (k units) Table 36. Global Bioactive Protein and Peptides Sales Market Share by Application (2021-2026) Table 37. Global Bioactive Protein and Peptides Sales Market Share by Application (2027-2032) Table 38. Global Bioactive Protein and Peptides Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 39. Global Bioactive Protein and Peptides Revenue by Application (2021-2026) & (k units) Table 40. Global Bioactive Protein and Peptides Revenue by Application (2027-2032) & (k units) Table 41. Global Bioactive Protein and Peptides Revenue Market Share by Application (2021-2026) Table 42. Global Bioactive Protein and Peptides Revenue Market Share by Application (2027-2032) Table 43. Global Bioactive Protein and Peptides Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Bioactive Protein and Peptides Sales by Region (2021-2026) & (k units) Table 45. Global Bioactive Protein and Peptides Sales Market Share by Region (2021-2026) Table 46. Global Bioactive Protein and Peptides Sales Forecasted by Region (2027-2032) & (k units) Table 47. Global Bioactive Protein and Peptides Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Bioactive Protein and Peptides Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. North America Bioactive Protein and Peptides Sales by Country (2021-2026) & (k units) Table 50. North America Bioactive Protein and Peptides Sales by Country (2027-2032) & (k units) Table 51. Europe Bioactive Protein and Peptides Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Europe Bioactive Protein and Peptides Sales by Country (2021-2026) & (k units) Table 53. Europe Bioactive Protein and Peptides Sales by Country (2027-2032) & (k units) Table 54. Asia Pacific Bioactive Protein and Peptides Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Asia Pacific Bioactive Protein and Peptides Sales by Country (2021-2026) & (k units) Table 56. Asia Pacific Bioactive Protein and Peptides Sales by Country (2027-2032) & (k units) Table 57. South America, Middle East and Africa Bioactive Protein and Peptides Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 58. South America, Middle East and Africa Bioactive Protein and Peptides Sales by Country (2021-2026) & (k units) Table 59. South America, Middle East and Africa Bioactive Protein and Peptides Sales by Country (2027-2032) & (k units) Table 60. Global Bioactive Protein and Peptides Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Bioactive Protein and Peptides Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Bioactive Protein and Peptides Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Bioactive Protein and Peptides Revenue Market Share by Region (2021-2026) Table 64. Global Bioactive Protein and Peptides Revenue Market Share by Region (2027-2032) Table 65. Gelita Company Information Table 66. Gelita Business Overview Table 67. Gelita Bioactive Protein and Peptides Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Gelita Bioactive Protein and Peptides Product Portfolio Table 69. Gelita Recent Development Table 70. Kerry Group Company Information Table 71. Kerry Group Business Overview Table 72. Kerry Group Bioactive Protein and Peptides Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Kerry Group Bioactive Protein and Peptides Product Portfolio Table 74. Kerry Group Recent Development Table 75. Vital Proteins Company Information Table 76. Vital Proteins Business Overview Table 77. Vital Proteins Bioactive Protein and Peptides Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Vital Proteins Bioactive Protein and Peptides Product Portfolio Table 79. Vital Proteins Recent Development Table 80. Rousselot Company Information Table 81. Rousselot Business Overview Table 82. Rousselot Bioactive Protein and Peptides Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Rousselot Bioactive Protein and Peptides Product Portfolio Table 84. Rousselot Recent Development Table 85. BRF Ingredients Company Information Table 86. BRF Ingredients Business Overview Table 87. BRF Ingredients Bioactive Protein and Peptides Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. BRF Ingredients Bioactive Protein and Peptides Product Portfolio Table 89. BRF Ingredients Recent Development Table 90. Bunge Ltd Company Information Table 91. Bunge Ltd Business Overview Table 92. Bunge Ltd Bioactive Protein and Peptides Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Bunge Ltd Bioactive Protein and Peptides Product Portfolio Table 94. Bunge Ltd Recent Development Table 95. Ingredia Nutritional Company Information Table 96. Ingredia Nutritional Business Overview Table 97. Ingredia Nutritional Bioactive Protein and Peptides Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Ingredia Nutritional Bioactive Protein and Peptides Product Portfolio Table 99. Ingredia Nutritional Recent Development Table 100. Gelatines Weishardt Company Information Table 101. Gelatines Weishardt Business Overview Table 102. Gelatines Weishardt Bioactive Protein and Peptides Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Gelatines Weishardt Bioactive Protein and Peptides Product Portfolio Table 104. Gelatines Weishardt Recent Development Table 105. PanTheryx Company Information Table 106. PanTheryx Business Overview Table 107. PanTheryx Bioactive Protein and Peptides Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. PanTheryx Bioactive Protein and Peptides Product Portfolio Table 109. PanTheryx Recent Development Table 110. Hubei Reborn Biotech Company Information Table 111. Hubei Reborn Biotech Business Overview Table 112. Hubei Reborn Biotech Bioactive Protein and Peptides Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Hubei Reborn Biotech Bioactive Protein and Peptides Product Portfolio Table 114. Hubei Reborn Biotech Recent Development Table 115. Seagarden Company Information Table 116. Seagarden Business Overview Table 117. Seagarden Bioactive Protein and Peptides Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Seagarden Bioactive Protein and Peptides Product Portfolio Table 119. Seagarden Recent Development Table 120. Shandong Hengxin Biotech Company Information Table 121. Shandong Hengxin Biotech Business Overview Table 122. Shandong Hengxin Biotech Bioactive Protein and Peptides Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Shandong Hengxin Biotech Bioactive Protein and Peptides Product Portfolio Table 124. Shandong Hengxin Biotech Recent Development Table 125. Baotou Dongbao Bio-Tech Company Information Table 126. Baotou Dongbao Bio-Tech Business Overview Table 127. Baotou Dongbao Bio-Tech Bioactive Protein and Peptides Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. Baotou Dongbao Bio-Tech Bioactive Protein and Peptides Product Portfolio Table 129. Baotou Dongbao Bio-Tech Recent Development Table 130. Wuhan Jiushengtang Biotech Company Information Table 131. Wuhan Jiushengtang Biotech Business Overview Table 132. Wuhan Jiushengtang Biotech Bioactive Protein and Peptides Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. Wuhan Jiushengtang Biotech Bioactive Protein and Peptides Product Portfolio Table 134. Wuhan Jiushengtang Biotech Recent Development Table 135. Morinaga Milk Company Information Table 136. Morinaga Milk Business Overview Table 137. Morinaga Milk Bioactive Protein and Peptides Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 138. Morinaga Milk Bioactive Protein and Peptides Product Portfolio Table 139. Morinaga Milk Recent Development Table 140. Collagile Company Information Table 141. Collagile Business Overview Table 142. Collagile Bioactive Protein and Peptides Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 143. Collagile Bioactive Protein and Peptides Product Portfolio Table 144. Collagile Recent Development Table 145. Nuritas Company Information Table 146. Nuritas Business Overview Table 147. Nuritas Bioactive Protein and Peptides Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 148. Nuritas Bioactive Protein and Peptides Product Portfolio Table 149. Nuritas Recent Development Table 150. SmartPEP Company Information Table 151. SmartPEP Business Overview Table 152. SmartPEP Bioactive Protein and Peptides Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 153. SmartPEP Bioactive Protein and Peptides Product Portfolio Table 154. SmartPEP Recent Development Table 155. Key Raw Materials Table 156. Raw Materials Key Suppliers Table 157. Bioactive Protein and Peptides Distributors List Table 158. Bioactive Protein and Peptides Customers List Table 159. Research Programs/Design for This Report Table 160. Authors List of This Report Table 161. Secondary Sources Table 162. Primary Sources List of Figures Figure 1. Bioactive Protein and Peptides Product Image Figure 2. Global Bioactive Protein and Peptides Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bioactive Protein and Peptides Market Size (2021-2032) & (US$ Million) Figure 4. Global Bioactive Protein and Peptides Sales (2021-2032) & (k units) Figure 5. Global Bioactive Protein and Peptides Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Bioactive Protein and Peptides Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Plant Source Image Figure 9. Animal Source Image Figure 10. Global Bioactive Protein and Peptides Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Bioactive Protein and Peptides Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Bioactive Protein and Peptides Sales Market Share by Type (2021-2032) Figure 13. Global Bioactive Protein and Peptides Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Bioactive Protein and Peptides Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Bioactive Protein and Peptides Revenue Market Share by Type (2021-2032) Figure 16. Functional Food Image Figure 17. Dietary Supplements Image Figure 18. Personal Care Image Figure 19. Animal Nutrition Image Figure 20. Other Image Figure 21. Global Bioactive Protein and Peptides Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Bioactive Protein and Peptides Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Bioactive Protein and Peptides Sales Market Share by Application (2021-2032) Figure 24. Global Bioactive Protein and Peptides Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Bioactive Protein and Peptides Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Bioactive Protein and Peptides Revenue Market Share by Application (2021-2032) Figure 27. North America Bioactive Protein and Peptides Sales and Growth Rate (2021-2032) & (k units) Figure 28. North America Bioactive Protein and Peptides Sales Market Share by Country (2021-2032) Figure 29. U.S. Bioactive Protein and Peptides Sales and Growth Rate (2021-2032) & (k units) Figure 30. Canada Bioactive Protein and Peptides Sales and Growth Rate (2021-2032) & (k units) Figure 31. Mexico Bioactive Protein and Peptides Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Bioactive Protein and Peptides Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Bioactive Protein and Peptides Sales Market Share by Country (2021-2032) Figure 34. Germany Bioactive Protein and Peptides Sales and Growth Rate (2021-2032) & (k units) Figure 35. France Bioactive Protein and Peptides Sales and Growth Rate (2021-2032) & (k units) Figure 36. U.K. Bioactive Protein and Peptides Sales and Growth Rate (2021-2032) & (k units) Figure 37. Italy Bioactive Protein and Peptides Sales and Growth Rate (2021-2032) & (k units) Figure 38. Netherlands Bioactive Protein and Peptides Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Bioactive Protein and Peptides Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Bioactive Protein and Peptides Sales Market Share by Country (2021-2032) Figure 41. China Bioactive Protein and Peptides Sales and Growth Rate (2021-2032) & (k units) Figure 42. Japan Bioactive Protein and Peptides Sales and Growth Rate (2021-2032) & (k units) Figure 43. South Korea Bioactive Protein and Peptides Sales and Growth Rate (2021-2032) & (k units) Figure 44. Southeast Asia Bioactive Protein and Peptides Sales and Growth Rate (2021-2032) & (k units) Figure 45. India Bioactive Protein and Peptides Sales and Growth Rate (2021-2032) & (k units) Figure 46. Australia Bioactive Protein and Peptides Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Bioactive Protein and Peptides Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Bioactive Protein and Peptides Sales Market Share by Country (2021-2032) Figure 49. Brazil Bioactive Protein and Peptides Sales and Growth Rate (2021-2032) & (k units) Figure 50. South Africa Bioactive Protein and Peptides Sales and Growth Rate (2021-2032) & (k units) Figure 51. Saudi Arabia Bioactive Protein and Peptides Sales and Growth Rate (2021-2032) & (k units) Figure 52. Turkey Bioactive Protein and Peptides Sales and Growth Rate (2021-2032) & (k units) Figure 53. Argentina Bioactive Protein and Peptides Sales and Growth Rate (2021-2032) & (k units) Figure 54. UAE Bioactive Protein and Peptides Sales and Growth Rate (2021-2032) & (k units) Figure 55. Egypt Bioactive Protein and Peptides Sales and Growth Rate (2021-2032) & (k units) Figure 56. Chile Bioactive Protein and Peptides Sales and Growth Rate (2021-2032) & (k units) Figure 57. Global Bioactive Protein and Peptides Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Bioactive Protein and Peptides Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Bioactive Protein and Peptides Revenue (2021-2032) & (US$ Million) Figure 60. North America Bioactive Protein and Peptides Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Bioactive Protein and Peptides Revenue (2021-2032) & (US$ Million) Figure 62. Europe Bioactive Protein and Peptides Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Bioactive Protein and Peptides Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Bioactive Protein and Peptides Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Bioactive Protein and Peptides Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Bioactive Protein and Peptides Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Bioactive Protein and Peptides Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Bioactive Protein and Peptides Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Plant Source
  • Animal Source
Applications
  • Functional Food
  • Dietary Supplements
  • Personal Care
  • Animal Nutrition
  • Other
Companies covered
  • Gelita
  • Kerry Group
  • Vital Proteins
  • Rousselot
  • BRF Ingredients
  • Bunge Ltd
  • Ingredia Nutritional
  • Gelatines Weishardt
  • PanTheryx
  • Hubei Reborn Biotech
  • Seagarden
  • Shandong Hengxin Biotech
  • Baotou Dongbao Bio-Tech
  • Wuhan Jiushengtang Biotech
  • Morinaga Milk
  • Collagile
  • Nuritas
  • SmartPEP

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Bioactive Protein and Peptides Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Bioactive Protein and Peptides Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Bioactive Protein and Peptides Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Bioactive Protein and Peptides Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Bioactive Protein and Peptides Market Dynamics
  1. 2.1 Bioactive Protein and Peptides Industry Trends
  2. 2.2 Bioactive Protein and Peptides Industry Drivers
  3. 2.3 Bioactive Protein and Peptides Industry Opportunities and Challenges
  4. 2.4 Bioactive Protein and Peptides Industry Restraints
3 Bioactive Protein and Peptides Market by Manufacturers
  1. 3.1 Global Bioactive Protein and Peptides Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Bioactive Protein and Peptides Sales by Manufacturers (2021-2026)
  3. 3.3 Global Bioactive Protein and Peptides Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Bioactive Protein and Peptides Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Bioactive Protein and Peptides Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Bioactive Protein and Peptides Manufacturers, Product Type & Application
  7. 3.7 Global Bioactive Protein and Peptides Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Bioactive Protein and Peptides Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Bioactive Protein and Peptides Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Bioactive Protein and Peptides Tier 1, Tier 2, and Tier 3
4 Bioactive Protein and Peptides Market by Type
  1. 4.1 Bioactive Protein and Peptides Type Introduction
  2. 4.1.1 Plant Source
  3. 4.1.2 Animal Source
  4. 4.2 Global Bioactive Protein and Peptides Sales by Type
  5. 4.2.1 Global Bioactive Protein and Peptides Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Bioactive Protein and Peptides Sales by Type (2021-2032)
  7. 4.2.3 Global Bioactive Protein and Peptides Sales Market Share by Type (2021-2032)
  8. 4.3 Global Bioactive Protein and Peptides Revenue by Type
  9. 4.3.1 Global Bioactive Protein and Peptides Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Bioactive Protein and Peptides Revenue by Type (2021-2032)
  11. 4.3.3 Global Bioactive Protein and Peptides Revenue Market Share by Type (2021-2032)
5 Bioactive Protein and Peptides Market by Application
  1. 5.1 Bioactive Protein and Peptides Application Introduction
  2. 5.1.1 Functional Food
  3. 5.1.2 Dietary Supplements
  4. 5.1.3 Personal Care
  5. 5.1.4 Animal Nutrition
  6. 5.1.5 Other
  7. 5.2 Global Bioactive Protein and Peptides Sales by Application
  8. 5.2.1 Global Bioactive Protein and Peptides Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Bioactive Protein and Peptides Sales by Application (2021-2032)
  10. 5.2.3 Global Bioactive Protein and Peptides Sales Market Share by Application (2021-2032)
  11. 5.3 Global Bioactive Protein and Peptides Revenue by Application
  12. 5.3.1 Global Bioactive Protein and Peptides Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Bioactive Protein and Peptides Revenue by Application (2021-2032)
  14. 5.3.3 Global Bioactive Protein and Peptides Revenue Market Share by Application (2021-2032)
6 Global Bioactive Protein and Peptides Sales by Region
  1. 6.1 Global Bioactive Protein and Peptides Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Bioactive Protein and Peptides Sales by Region (2021-2032)
  3. 6.2.1 Global Bioactive Protein and Peptides Sales by Region (2021-2026)
  4. 6.2.2 Global Bioactive Protein and Peptides Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Bioactive Protein and Peptides Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Bioactive Protein and Peptides Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Bioactive Protein and Peptides Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Bioactive Protein and Peptides Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Bioactive Protein and Peptides Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Bioactive Protein and Peptides Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Bioactive Protein and Peptides Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Bioactive Protein and Peptides Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Bioactive Protein and Peptides Revenue by Region
  1. 7.1 Global Bioactive Protein and Peptides Revenue by Region
  2. 7.1.1 Global Bioactive Protein and Peptides Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Bioactive Protein and Peptides Revenue by Region (2021-2026)
  4. 7.1.3 Global Bioactive Protein and Peptides Revenue by Region (2027-2032)
  5. 7.1.4 Global Bioactive Protein and Peptides Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Bioactive Protein and Peptides Revenue (2021-2032)
  8. 7.2.2 North America Bioactive Protein and Peptides Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Bioactive Protein and Peptides Revenue (2021-2032)
  11. 7.3.2 Europe Bioactive Protein and Peptides Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Bioactive Protein and Peptides Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Bioactive Protein and Peptides Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Bioactive Protein and Peptides Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Bioactive Protein and Peptides Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Gelita
  2. 8.1.1 Gelita Company Information
  3. 8.1.2 Gelita Business Overview
  4. 8.1.3 Gelita Bioactive Protein and Peptides Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Gelita Bioactive Protein and Peptides Product Portfolio
  6. 8.1.5 Gelita Recent Developments
  7. 8.2 Kerry Group
  8. 8.2.1 Kerry Group Company Information
  9. 8.2.2 Kerry Group Business Overview
  10. 8.2.3 Kerry Group Bioactive Protein and Peptides Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Kerry Group Bioactive Protein and Peptides Product Portfolio
  12. 8.2.5 Kerry Group Recent Developments
  13. 8.3 Vital Proteins
  14. 8.3.1 Vital Proteins Company Information
  15. 8.3.2 Vital Proteins Business Overview
  16. 8.3.3 Vital Proteins Bioactive Protein and Peptides Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Vital Proteins Bioactive Protein and Peptides Product Portfolio
  18. 8.3.5 Vital Proteins Recent Developments
  19. 8.4 Rousselot
  20. 8.4.1 Rousselot Company Information
  21. 8.4.2 Rousselot Business Overview
  22. 8.4.3 Rousselot Bioactive Protein and Peptides Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Rousselot Bioactive Protein and Peptides Product Portfolio
  24. 8.4.5 Rousselot Recent Developments
  25. 8.5 BRF Ingredients
  26. 8.5.1 BRF Ingredients Company Information
  27. 8.5.2 BRF Ingredients Business Overview
  28. 8.5.3 BRF Ingredients Bioactive Protein and Peptides Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 BRF Ingredients Bioactive Protein and Peptides Product Portfolio
  30. 8.5.5 BRF Ingredients Recent Developments
  31. 8.6 Bunge Ltd
  32. 8.6.1 Bunge Ltd Company Information
  33. 8.6.2 Bunge Ltd Business Overview
  34. 8.6.3 Bunge Ltd Bioactive Protein and Peptides Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Bunge Ltd Bioactive Protein and Peptides Product Portfolio
  36. 8.6.5 Bunge Ltd Recent Developments
  37. 8.7 Ingredia Nutritional
  38. 8.7.1 Ingredia Nutritional Company Information
  39. 8.7.2 Ingredia Nutritional Business Overview
  40. 8.7.3 Ingredia Nutritional Bioactive Protein and Peptides Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Ingredia Nutritional Bioactive Protein and Peptides Product Portfolio
  42. 8.7.5 Ingredia Nutritional Recent Developments
  43. 8.8 Gelatines Weishardt
  44. 8.8.1 Gelatines Weishardt Company Information
  45. 8.8.2 Gelatines Weishardt Business Overview
  46. 8.8.3 Gelatines Weishardt Bioactive Protein and Peptides Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Gelatines Weishardt Bioactive Protein and Peptides Product Portfolio
  48. 8.8.5 Gelatines Weishardt Recent Developments
  49. 8.9 PanTheryx
  50. 8.9.1 PanTheryx Company Information
  51. 8.9.2 PanTheryx Business Overview
  52. 8.9.3 PanTheryx Bioactive Protein and Peptides Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 PanTheryx Bioactive Protein and Peptides Product Portfolio
  54. 8.9.5 PanTheryx Recent Developments
  55. 8.10 Hubei Reborn Biotech
  56. 8.10.1 Hubei Reborn Biotech Company Information
  57. 8.10.2 Hubei Reborn Biotech Business Overview
  58. 8.10.3 Hubei Reborn Biotech Bioactive Protein and Peptides Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Hubei Reborn Biotech Bioactive Protein and Peptides Product Portfolio
  60. 8.10.5 Hubei Reborn Biotech Recent Developments
  61. 8.11 Seagarden
  62. 8.11.1 Seagarden Company Information
  63. 8.11.2 Seagarden Business Overview
  64. 8.11.3 Seagarden Bioactive Protein and Peptides Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Seagarden Bioactive Protein and Peptides Product Portfolio
  66. 8.11.5 Seagarden Recent Developments
  67. 8.12 Shandong Hengxin Biotech
  68. 8.12.1 Shandong Hengxin Biotech Company Information
  69. 8.12.2 Shandong Hengxin Biotech Business Overview
  70. 8.12.3 Shandong Hengxin Biotech Bioactive Protein and Peptides Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Shandong Hengxin Biotech Bioactive Protein and Peptides Product Portfolio
  72. 8.12.5 Shandong Hengxin Biotech Recent Developments
  73. 8.13 Baotou Dongbao Bio-Tech
  74. 8.13.1 Baotou Dongbao Bio-Tech Company Information
  75. 8.13.2 Baotou Dongbao Bio-Tech Business Overview
  76. 8.13.3 Baotou Dongbao Bio-Tech Bioactive Protein and Peptides Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Baotou Dongbao Bio-Tech Bioactive Protein and Peptides Product Portfolio
  78. 8.13.5 Baotou Dongbao Bio-Tech Recent Developments
  79. 8.14 Wuhan Jiushengtang Biotech
  80. 8.14.1 Wuhan Jiushengtang Biotech Company Information
  81. 8.14.2 Wuhan Jiushengtang Biotech Business Overview
  82. 8.14.3 Wuhan Jiushengtang Biotech Bioactive Protein and Peptides Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Wuhan Jiushengtang Biotech Bioactive Protein and Peptides Product Portfolio
  84. 8.14.5 Wuhan Jiushengtang Biotech Recent Developments
  85. 8.15 Morinaga Milk
  86. 8.15.1 Morinaga Milk Company Information
  87. 8.15.2 Morinaga Milk Business Overview
  88. 8.15.3 Morinaga Milk Bioactive Protein and Peptides Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Morinaga Milk Bioactive Protein and Peptides Product Portfolio
  90. 8.15.5 Morinaga Milk Recent Developments
  91. 8.16 Collagile
  92. 8.16.1 Collagile Company Information
  93. 8.16.2 Collagile Business Overview
  94. 8.16.3 Collagile Bioactive Protein and Peptides Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Collagile Bioactive Protein and Peptides Product Portfolio
  96. 8.16.5 Collagile Recent Developments
  97. 8.17 Nuritas
  98. 8.17.1 Nuritas Company Information
  99. 8.17.2 Nuritas Business Overview
  100. 8.17.3 Nuritas Bioactive Protein and Peptides Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Nuritas Bioactive Protein and Peptides Product Portfolio
  102. 8.17.5 Nuritas Recent Developments
  103. 8.18 SmartPEP
  104. 8.18.1 SmartPEP Company Information
  105. 8.18.2 SmartPEP Business Overview
  106. 8.18.3 SmartPEP Bioactive Protein and Peptides Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 SmartPEP Bioactive Protein and Peptides Product Portfolio
  108. 8.18.5 SmartPEP Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Bioactive Protein and Peptides Value Chain Analysis
  2. 9.1.1 Bioactive Protein and Peptides Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Bioactive Protein and Peptides Production Mode & Process
  6. 9.2 Bioactive Protein and Peptides Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Bioactive Protein and Peptides Distributors
  9. 9.2.3 Bioactive Protein and Peptides Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst